Form D to Follow: Symbiotic Health $850000 Financing. Gerard Honig Published Oct 11 D Form

Biotechnology Symbiotic Health, Inc. - Gerard Honig

Symbiotic Health Financing

Symbiotic Health, Inc., Corporation just submitted form D because of $850,000 equity financing. The date of first sale was 2015-09-04. Symbiotic Health was able to finance itself with $850,000. That is 100.00% of the fundraising. The total financing amount was $850,000. This form was filed on 2016-10-11. The reason for the financing was: unspecified.

Symbiotic Health is based in Alabama. The company’s business is Biotechnology. The form D was submitted by Gerard Honig Director. The company was incorporated in 2013. The filler’s address is: 3 Expressway Plaza Suite 100, Roslyn Heights, Ny, New York, 11577. Gerard Honig is the related person in the form and it has address: 3 Expressway Plaza Suite 100, Roslyn Heights, Ny, New York, 11577. Link to Symbiotic Health Filing: 000165353416000003.

Analysis of Symbiotic Health Offering

On average, startups in the Biotechnology sector, sell 73.77% of the total offering amount. Symbiotic Health sold 100.00% of the offering. Could this mean that the trust in Symbiotic Health is high? The average offering size for companies in the Biotechnology industry is $3.08 million. The offering was 72.40% smaller than the average of $3.08 million. Of course this should not be seen as negative. Companies get financed for a variety of reasons and needs. The minimum investment for this financing is set at $500000. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Symbiotic Health Also

The Form D signed by Gerard Honig might help Symbiotic Health, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment